Viatris Bets On Value-Added Medicines To Boost Growth

Firm Targets 5%-6% Growth Through Higher-Margin Portfolio And Operational Restructuring Program

 
• By Dean Rudge
  
Added Value
• Source: Shutterstock

More from Value Added Medicines

More from Products